期刊文献+

B_(23)-Gly-B_(24)人胰岛素的分离纯化及性质研究 被引量:2

Purification and Characterization of B_23-Gly-B_24 Human Insulin
下载PDF
导出
摘要 为了研究胰岛素B链羧端的自由度对于胰岛素与受体相互作用的影响。在人胰岛素B链羧端(转角区回折点B23与B24之间插入一个Gly。B23-Gly-B24人胰岛素原在大肠杆菌的表达产物占细胞总蛋白量的28%,B23-Gly-B24人胰岛素的受体活性分别是标准猪胰岛素的122%和人胰岛素的111%。说明以较高的受体结合活性获得了高纯度的B23-Gly-B24人胰岛素。 In order to study the effect of increased flexibility of C-terminal of insulin B chain on its receptor binding activity, a Gly was inserted between B23 and B24, of insulin B chain β turn in hope of providing more flexibility to its C terminal. The expression level of 823-Gly-B24 Human prolnsulin accounted for 28% of total bacterial proteins. B23-Gly-B24 human insulin's receptor binding activity is 122% as compared with standard porcine insulin. Purified B23-Gly-B24 Human Insulin was obtained by the common methods and it's receptor binding activity was high.
作者 陈来同 姚蒙
出处 《药物生物技术》 CAS CSCD 2002年第5期270-273,共4页 Pharmaceutical Biotechnology
基金 北京大学蛋白质工程及基因工程国家重点实验室资助项目
关键词 B23-Gly-B24人胰岛素原 受体结合活性 非融合方式 B链C端柔性 分离 纯化 B23-Gly-b24 Human Proinsulin, Receptor binding activity, Non-fusion,Flexibility of C terminal of B chain
  • 相关文献

参考文献3

二级参考文献10

共引文献8

同被引文献32

  • 1陈来同,黄春媚,张曼,杨志茹,胡美浩.去B链羧端三肽人胰岛素的分离纯化及其性质研究[J].生物化学杂志,1996,12(2):187-190. 被引量:5
  • 2冷雪,陈劲春,董鹏.重组人胰岛素及C肽的分离纯化[J].北京化工大学学报(自然科学版),2006,33(5):30-32. 被引量:1
  • 3Frost T, Rave K, Pfuetzner A, et al. Effects of C-peptide on glucose metabolism in patients with type 1 diabetes[J]. Diabetes Care, 2002, 25(6). 1096-1097.
  • 4Tang J G, Hu M H. Production of human proinsulin in F.. coli in a non-fusion form[J]. Biotechnology Letters, 1993, 15(7) :661 - 666.
  • 5Ruoppolo M, Freedman R B. Refolding by disulfide isomerization: the mixed disulfide between ribonuclease T1 and glutathione as a model refolding substrate [ J ]. Biochemistry, 1995, 34(4) : 9380- 9388.
  • 6Xie Y, Wetlaufer D B. Control of aggregation in protein refolding: The temperature-leap tactic [ J ]. Protein Science, 1996, 5(3) :517- 523.
  • 7张婷婷,叶波平.包涵体蛋白质的复性研究进展[J].药物生物技术,2007,14(4):306-309. 被引量:25
  • 8DV Goeddel, DG Kleid, F Bolivar, et al. Expression in escherichia coli of chemically synthesized genes for human insulin[J], Proc Natl Acad Sci USA, 1979, 76:106
  • 9H Keen, A Glynne, J C Pickup, et al. Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men[J]. Lancet, 1980,2:398
  • 10Zinman B . The physiological replacement of insulin: an elusive goal[J]. New Engl J Med, 1989, 321(6):363

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部